iCAD ’s AI Solution Has Exceptional Results in Study

iCAD’s digital breast tomosynthesis cancer detection software could make a big splash at the upcoming Radiological Society of North America meeting if recent study results are any indication. The solution will also be displayed at The European Society of Breast Imaging annual meeting, occurring this weekend. The Nashua, NH-based company said its software, which incorporates artificial intelligence (AI) and machine learning, had exceptional study results that demonstrated significant advantages for digital breast tomosynthesis. In the study, 24 radiologists reviewed about 260 3D exams. Of that number, 65 were cancers, the company said. The findings confirmed iCAD’s solution to support the fact that digital breast tomosynthesis increased improvements in both reader sensitivity (8% on average) and specificity (6.9% on average). In addition, when reading tomosynthesis cases with the solution, radiologists’ reading times were reduced by more than half (52.7% on average). “What we achieved in sensitivity, which is your cancer’s detection accuracy, is an 8% increase when the radiologists were reading using our tool vs. when they read the exams without it – and that’s big,” Ken Ferry, iCAD CEO, told MD+DI. Currently, the solution is approved outside of the US. However, Ferry said he is hoping that iCAD will be getting much closer to an FDA no...
Source: MDDI - Category: Medical Devices Authors: Tags: Business Imaging Source Type: news

Related Links:

Authors: Jaiswal K, Hull M, Furniss AL, Doyle R, Gayou N, Bayliss E Abstract Background: Timely detection and treatment of breast cancer is important in optimizing survival and minimizing recurrence. Given disparities in breast cancer outcomes based on socioeconomic status, we examined time to diagnosis and treatment in a safety-net hospital. Methods: We conducted a retrospective review of all patients with breast cancer diagnosed between July 1, 2010, and June 30, 2012 (N=120). We limited our analytic sample to patients with nonrecurrent, primary stage 0-III breast cancer (N=105) and determined intervals from pres...
Source: Journal of the National Comprehensive Cancer Network : JNCCN - Category: Cancer & Oncology Tags: J Natl Compr Canc Netw Source Type: research
Breast cancer screening with digital mammography is effective at finding life-threatening...Read more on AuntMinnie.comRelated Reading: Canadian guidelines recommend against early mammography DBT betters mammo performance in screening, diagnosis CEDM reduces biopsies of benign breast lesions DBT maintains high performance over time DBT doesn't hurt screening throughput
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
The transition from digital mammography to digital breast tomosynthesis (DBT)...Read more on AuntMinnie.comRelated Reading: DBT betters mammo performance in screening, diagnosis DBT maintains high performance over time DBT doesn't hurt screening throughput DBT spots 34% more breast cancers than mammography DBT plus ABVS offers a breast cancer staging alternative
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
ConclusionsThese findings do not support the notion that diagnostic and treatment delays following a first healthcare contact are more common in women diagnosed with breast cancer during or shortly after pregnancy. However, there was some evidence of delays in seeking healthcare among pregnant and lactating women.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research
Abstract Sarcomas of the breast belong to a heterogeneous group of breast tumors of mesenchymal origin, without epithelial components. These tumors can be primary or secondary (after previous treatment for breast cancer), are rare, present aggressive behavior, and have a poor prognosis. They occur mainly in women between 45 and 50 years of age, with the exception of angiosarcomas, which can occur in younger patients. Clinically, breast sarcomas manifest as palpable, mobile, rapidly growing masses, without skin thickening, axillary lymphadenopathy, or nipple discharge. Although the imaging findings are non specific, they ca...
Source: Radiologia Brasileira - Category: Radiology Source Type: research
AbstractPurposeIncrease in in situ breast cancer (BCIS) incidence has been reported across Europe and the USA. However, little is known about the trends in BCIS incidence in regions without population-based mammographic screening programs. We set out to investigate these trends in Zurich, Switzerland, where only opportunistic mammographic screening exists.MethodsData from 989 women diagnosed with a primary BCIS between 2003 and 2014 were used in our analyses. Age-standardized incidence rates per 100,000 person-years (ASR) were computed per year. Additional analyses by BCIS subtype, by age group at diagnosis and by incidenc...
Source: Journal of Cancer Research and Clinical Oncology - Category: Cancer & Oncology Source Type: research
Conclusion.In low‐ or middle‐income countries, where BC screening programs do not effectively reach the target population, it is crucial to focus efforts in identifying and prioritizing symptomatic patients or those with abnormal imaging studies to ultimately downstage BC. Alerta Rosa proved to be successful in reducing health system intervals and could be replicated and adapted for other limited resource settings.Implications for Practice.In countries such as Mexico, infrastructure and financial drawbacks limit the implementation of effective screening mammography programs. This article presents a novel and effective ...
Source: The Oncologist - Category: Cancer & Oncology Authors: Tags: Breast Cancer, Global Health and Cancer Source Type: research
Abstract Although the primary purpose of periodic mammograms in screening programs is to identify lesions suspected of being carcinomas, the findings are often related to systemic (benign or malignant) diseases, rather than breast cancer. Although the involvement of breast structures in systemic diseases is unusual, it can be included in the differential diagnosis of masses, skin changes, calcifications, asymmetry, and axillary lymphadenopathy. The main diagnostic entities that can be associated with such involvement are diabetes, chronic kidney disease, heart diseases, connective tissue diseases, HIV infection, lymphoma, ...
Source: Radiologia Brasileira - Category: Radiology Source Type: research
Abstract Although the primary purpose of periodic mammograms in screening programs is to identify lesions suspected of being carcinomas, the findings are often related to systemic (benign or malignant) diseases, rather than breast cancer. Although the involvement of breast structures in systemic diseases is unusual, it can be included in the differential diagnosis of masses, skin changes, calcifications, asymmetry, and axillary lymphadenopathy. The main diagnostic entities that can be associated with such involvement are diabetes, chronic kidney disease, heart diseases, connective tissue diseases, HIV infection, lymphoma, ...
Source: Radiologia Brasileira - Category: Radiology Source Type: research
Abstract Although the primary purpose of periodic mammograms in screening programs is to identify lesions suspected of being carcinomas, the findings are often related to systemic (benign or malignant) diseases, rather than breast cancer. Although the involvement of breast structures in systemic diseases is unusual, it can be included in the differential diagnosis of masses, skin changes, calcifications, asymmetry, and axillary lymphadenopathy. The main diagnostic entities that can be associated with such involvement are diabetes, chronic kidney disease, heart diseases, connective tissue diseases, HIV infection, lymphoma, ...
Source: Radiologia Brasileira - Category: Radiology Source Type: research
More News: Cancer | Cancer & Oncology | Learning | Mammography | Radiology | Study | Universities & Medical Training